about
Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in ratsMg,Al layered double hydroxides with intercalated indomethacin: synthesis, characterization, and pharmacological study.The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells.Vav3 is involved in GABAergic axon guidance events important for the proper function of brainstem neurons controlling cardiovascular, respiratory, and renal parameters.Transcriptional factor aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogeneGenetic dissection of the vav2-rac1 signaling axis in vascular smooth muscle cells.JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction.Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions.Blocking 5-HT2 receptor restores cardiovascular disorders in type 1 experimental diabetes.Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5.Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.Chronic treatment with pravastatin prevents early cardiovascular changes in spontaneously hypertensive rats.In vitro antioxidant activity of pravastatin provides vascular protection.Antihistaminic activity of pulegone on the guinea-pig ileum.Beneficial effects of trandolapril in uninephrectomized spontaneously hypertensive rats: role of cyclooxygenase pathway.Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats.Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis.Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.MR-14134, a new benzothiazepine with central hypotensive action.Long-term intake of a milk casein hydrolysate attenuates the development of hypertension and involves cardiovascular benefitsVav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanismsVagal afferents contribute to sympathoexcitation-driven metabolic dysfunctionsPharmacologic screening and antimicrobial activity of the essential oil of Calamintha sylvatica subsp. ascendensPharmacologic effects of lactones isolated from Pulsatilla alpina subsp. apiifoliaPharmacological screening and antimicrobial activity of the essential oil of Artemisia caerulescens subsp. gallicaAnalgesic, antipyretic and anti-inflammatory activity of the essential oil of Artemisia caerulescens subsp. gallicaSedating and antipyretic activity of the essential oil of Calamintha sylvatica subsp. ascendensAntispasmodic activity of benzylisoquinoline alkaloids analogous to papaverineGastric antisecretory and antiulcer activities of an ethanolic extract of Bidens pilosa L. var. radiata Schult. BipSynthesis and inotropic activity of hydroindene derivativesMesenteric cyclooxygenase products after combined antihypertensive treatment in uninephrectomized SHRsPharmacology of JB-9315, a new selective histamine H2-receptor antagonistAntihypertensive action of trandolapril and verapamil in spontaneously hypertensive rats after unilateral nephrectomyAntihypertensive effect of trandolapril and verapamil in rats with induced hypertensionHydroindenic-guanylhydrazones. Synthesis and evaluation as inotropic agentsAcute effect of whey peptides upon blood pressure of hypertensive rats, and relationship with their angiotensin-converting enzyme inhibitory activityAstaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive ratsDihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agentsImplication of Opioid Receptors in the Antihypertensive Effect of a Bovine Casein Hydrolysate and αs1-Casein-Derived Peptides
P50
Q21558791-7BB170A8-2E3C-4D05-A891-0EB663038E04Q31056935-948362F9-CFF6-45A8-BE45-94A98BC05718Q33559599-E55E65F3-04E2-491D-8426-9F8046B6B5D5Q34361011-984C64AB-D09C-4E37-9326-67657041D63FQ34509506-31E7B1E4-42AB-44CB-A1BA-A62692AFA950Q34592816-03BE1B95-773B-4019-A60C-413080D13FB3Q35872570-323D80AE-75F3-4743-A619-669789008D8DQ36019359-51CA8C41-BC36-41AA-9E57-7E8BFD20BC0BQ36070023-11EC6A37-BCFB-4A2F-9677-DDB00F6C4294Q37278065-AE60D558-D879-47BC-BBFA-744B2C8970CCQ37805535-A2B30F16-1042-4FA2-81F6-245E699740B8Q39360812-7BBEE907-AE99-44EB-9271-EC52A12D3211Q41906208-F9785C98-D351-44C8-92DD-B76DA7F335A8Q43203599-D10BB38A-F102-419C-AA0F-411BEA14597FQ43626914-B6572897-FFE0-44EB-997F-FE064F3EB2D9Q44208468-95C238D9-3B27-47AE-8E15-EB78FA3B8F96Q44576724-4B954214-DF12-4EA9-A587-4147B40603B9Q48152427-12B794D8-8283-4DB2-B03C-BFEAC817AEA4Q51460294-CA09DC13-80F8-490C-813B-871F44C97459Q51596912-9F50C161-084C-4E2D-BE7A-71C0684CF8C2Q60167787-4C23524F-0B9D-4C16-A95F-9C0C0ED4700EQ63884112-162CCAFF-B97C-414A-BF3D-D028FDC77136Q64079776-571F4FD9-06C7-48E4-AF4C-6DD2239E9E64Q67972831-013B58BB-F530-4FD3-BA84-5B65833C5C30Q68105500-FB9DA76E-E15E-452E-B4A6-31C694F5FDD2Q69409642-886E1D0A-1F93-4564-92C5-589C2E8EDBA6Q69431038-B74A4695-45F6-4A7D-88ED-7FE92C1910E7Q69741191-6359A601-30C6-4B05-83A6-C2AB6FEEA8ACQ70581382-717E2D14-DA1A-4BEA-90C4-BC2BE5BDF94EQ73315806-0806B957-126B-4605-91BA-EDEFED28DF62Q73409208-7440FF36-D32B-4844-9909-37EAE72834D7Q73647658-32C54CF1-600B-4989-AF07-E5A141016569Q74313773-D5807A0E-C0F7-461D-9009-DDE738AC16EDQ77077241-28691649-53B9-4B98-B811-37F6D3596654Q77395908-AEF3846D-D95A-44C1-8101-5506370FA7A9Q77749778-520E43B1-AE41-4024-837A-B75338433807Q82837592-6A30EDD8-8851-4962-AB12-041DAC5E8C0EQ85089418-B0BD6D2E-2B80-4AAD-990E-E09C94074D20Q91046603-F42963CA-8A01-4CC2-BDAF-41C01AB09628Q92554992-2F849AB3-6954-4402-8A05-7918A639DAAE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
María J Montero
@ast
María J Montero
@en
María J Montero
@es
María J Montero
@nl
type
label
María J Montero
@ast
María J Montero
@en
María J Montero
@es
María J Montero
@nl
prefLabel
María J Montero
@ast
María J Montero
@en
María J Montero
@es
María J Montero
@nl
P106
P1153
35566423100
P21
P31
P496
0000-0003-2125-0378